Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $3000.0.

  • PAVmed's Capital Expenditures changed N/A to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $21000.0, marking a year-over-year change of. This contributed to the annual value of $55000.0 for FY2024, which is 7727.27% down from last year.
  • Latest data reveals that PAVmed reported Capital Expenditures of $3000.0 as of Q3 2025.
  • PAVmed's 5-year Capital Expenditures high stood at $574000.0 for Q1 2022, and its period low was $3000.0 during Q2 2024.
  • In the last 4 years, PAVmed's Capital Expenditures had a median value of $22000.0 in 2023 and averaged $132000.0.
  • Per our database at Business Quant, PAVmed's Capital Expenditures crashed by 9781.42% in 2024 and then surged by 16666.67% in 2025.
  • Over the past 4 years, PAVmed's Capital Expenditures (Quarter) stood at $298000.0 in 2022, then plummeted by 38.59% to $183000.0 in 2023, then plummeted by 97.81% to $4000.0 in 2024, then dropped by 25.0% to $3000.0 in 2025.
  • Its Capital Expenditures was $3000.0 in Q3 2025, compared to $8000.0 in Q2 2025 and $6000.0 in Q1 2025.